NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-001-2007-0-US-01 Vaccine Designed For Long-lasting And Transmission-blocking Activity Of Antibodies To Plasmodium Falciparum Elicited In Mice By Protein Conjugates Of PFS25 US 60/851,961 Abandoned
NIAID E-173-2004-1-ZA-09 Methods of Using Adenoviral Vector to Induced an Immune Response ZA National Stage 200608512 Abandoned
NIA E-243-2005-0-PCT-02 SUSCEPTIBILITY-MATCHED MULTI-WELL SAMPLE HOLDERS FOR HIGH-THROUGHPUT SCREENING BY MAGNETIC ANALYSIS PCT PCT PCT/US2006/039048 Expired
NIAMS E-028-2006-0-PCT-02 Means And Methods For The Prediction Of Joint Destruction PCT PCT PCT/EP06/009884 Expired
NIAMS E-028-2006-0-CA-05 Means And Methods For The Prediction Of Joint Destruction CA National Stage 2625446 Abandoned
NHGRI E-312-2006-0-US-01 METHOD OF DETECTING AND TREATING ATTENTION DEFICIT/HYPERACTIVITY DISORDER US 60/850,972 Abandoned
NCI E-124-2004-2-US-03 DIAGNOSTIC TOOL FOR DIAGNOSING BENIGN VERSUS MALIGNANT THYROID LESIONS US National Stage 11/547,995 7901881 Issued PDF
NIAID E-173-2004-1-US-08 Method of Using Adenoviral Vector to Induce an Immune Response US National Stage 11/578,096 Abandoned
NCI E-126-2006-0-US-01 Benzindole derivatives and method of treating HIV/AIDS US 60/850,437 Abandoned
NIAID E-306-2006-0-US-01 Avain Influenza Vaccine US 60/850,761 Abandoned
NINDS E-153-2005-0-US-01 PREVENTION AND TREATMENT OF INFLAMMATORY DEMYELINATION OR AUTOIMMUNE DISORDERS US 60/828,732 Abandoned
NCI E-227-2006-0-US-01 Prevention Of Tissue Ischemia US 60/850,132 Abandoned
NIEHS E-011-2008-0-US-01 Method For Determination Of DHT Levels In Tissue Samples US 60/850,028 Abandoned
NIDDK E-063-2007-1-US-01 Delivery Of Cross Species A3 Adenosine-receptor Antagonist To Reduce Intracoular Pressure US 60/850,175 Abandoned
NCI E-288-2006-0-US-01 Cyclic Phosphopeptide Inhibitors Of Protein 2c Delta, WIP1 US 60/850,218 Abandoned
NINDS E-039-2006-0-PCT-02 Octanol Formulations And Methods Of Treatment Using The Same PCT PCT PCT/US2006/38892 Expired
NINDS E-005-2004-0-US-02 Biomarkers That Allow The Prediction Of Responder- And Non-responder Status To Interferon-beta In Multiple Sclerosis (MS) US National Stage 11/578,207 Abandoned
NIDDK E-104-1989-0-US-17 BIOLOGICALLY ACTIVE SYNTHETIC THYROTROPIN AND CLONED GENE FOR PRODUCING SAME US CON 11/543,498 Abandoned
NCI E-072-2001-0-US-04 Identification of New Small RNAs and ORFS and ORFS of E. Coli as Mediatiors of Cell and Intercell Regulation US DIV 11/543,601 Abandoned
NINDS E-039-2006-0-EP-04 Octanol Formulations And Methods Of Treatment Using The Same EP National Stage 06825479.6 Abandoned
NIDCR E-131-1998-0-MX-32 Thymosin B4 Promotes Wound Repair MX DIV PA/a/2006/011543 Expired
NINDS E-039-2006-0-CA-03 Octanol Formulations And Methods Of Treatment Using The Same CA National Stage 2624546 Abandoned
NCI E-264-2006-0-US-01 Stilbenedisulfonic Acid Derivatives As Inhibitors Of HIV-I Integrase US 60/849,718 Abandoned
NCI E-194-1994-0-JP-42 SUBSTITUTED O6-BENZYLGUANINES AND 6(4) - BENZYLOXPYRIMIDINES JP DIV 273447/2006 Abandoned
NINDS E-261-2004-0-JP-04 Peptidic Compound Mixtures As Therapeutic Agents In CNS Autoimmunity JP National Stage 2006-551535 Abandoned
NCI E-319-2006-0-US-01 Mutant Alleles Of HSP90 That Modulate The Lifespan Of Yeast (and Potentially Of Higher Organisms Including Humans) US 60/848,346 Abandoned
NCI E-104-2007-0-US-02 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence US ORD 11/529,938 8217222 Issued PDF
NCI E-104-2007-0-EP-07 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence EP National Stage 06815994.6 Issued
NCI E-021-2001-0-AU-09 Chromosome 3p21.3 Genes Are Tumor Suppressors AU DIV 2006222760 Expired
NCI E-265-2005-0-PCT-02 Modified Recombinant Anti-Tumor RNase PCT PCT PCT/US2006/038180 Abandoned
NCI E-104-2007-0-PCT-03 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence PCT PCT PCT/US06/038396 Expired
NCI E-104-2007-0-AU-05 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence AU National Stage 2006299539 Abandoned
NCI E-104-2007-0-CA-06 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence CA National Stage 2624213 Abandoned
NCI E-104-2007-0-KR-04 Methods For Identifing Markers For Early-stage Human Cancer, Cancer Progression And Recurrence KR National Stage 1020087010596 Pending
NIA E-027-2005-0-PCT-02 Chemoattractant-based Toxins Which Deplete T Regulatory Cells To Improve Vaccine Immune Responses For Cancer And Other Clinically Relevant Diseases PCT PCT PCT/US2006/038195 Expired
NIA E-027-2005-0-EP-05 Chemoattractant-based Toxins Which Deplete T Regulatory Cells To Improve Vaccine Immune Responses For Cancer And Other Clinically Relevant Diseases EP National Stage 06825277.4 Abandoned
NIA E-027-2005-0-AU-03 Chemoattractant-based Toxins Which Deplete T Regulatory Cells To Improve Vaccine Immune Responses For Cancer And Other Clinically Relevant Diseases AU National Stage 2006297126 Abandoned
NIA E-027-2005-0-CA-04 Chemoattractant-based Toxins Which Deplete T Regulatory Cells To Improve Vaccine Immune Responses For Cancer And Other Clinically Relevant Diseases CA National Stage 2624662 Abandoned
NIAMS E-309-2006-1-US-01 Cell-nanofiber Composite And Cell-nanofiber Composite Amalgam Based Engineered Intervertebra Disc. US 60/848,284 Abandoned
NCI E-335-2005-1-US-01 Targeted Detection, Fluorescence Imaging, And Photo-Dynamic Therapy Of Disseminated Intraperitoneal Cancer Metastases4239-72148-02 US 60/848,082 Abandoned
NIAID E-039-1999-0-US-08 A Novel Chimeric Protein for Prevention and Treatment of HIV Infection US CON 11/535,957 8420099 Abandoned PDF
NCI E-286-2006-0-US-01 SCGB3A2 AS A GROWTH FACTOR AND ANTI-APOPTOTIC AGENT US 60/847,747 Abandoned
NIAMS E-309-2006-0-US-01 Cell-nanofiber Composite And Cell-nanofiber Composite Amalgam Based Engineered Intervertebral Disc US 60/847,839 Abandoned
NCI E-304-2006-0-US-01 MODIFIED T CELL RECEPTORS AND RELATED MATERIALS AND METHODS US 60/847,447 Abandoned
NCI E-265-1999-2-US-01 INHIBITION OF CELL MOTILITY AND ANGIOGENESIS US CIP 11/525,672 7871981 Abandoned PDF
NCI E-133-2004-0-US-03 CARBOHYDRATE-ENCAPSULATED QUANTUM DOTS FOR BIOLOGICAL IMAGING US ORD 10/594,075 Abandoned
NIDDK E-308-2006-0-US-01 (S,S)-trans-1,2-cyclopentane Diamine-modified And Gamma-lysine-modified Peptide Nucleic Acids As Probes For Nucleic Acid Detection: Synthesis And Applications US 60/846,354 Abandoned
NCI E-311-2006-0-US-01 Compositions and Methods for Chitosan Enhanced Immune Response US 60/846,481 Abandoned
NCI E-303-2003-0-US-08 Cellular and Viral Inactivation US National Stage 11/525,250 8268602 Abandoned PDF
NCI E-167-1997-0-US-24 USE OF A NITROXIDE OR A PRODRUG THEREOF IN THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF CANCER US CON 11/524,753 Abandoned